Stock Analysis | DuPont de Nemours Outlook - A Stock Under Technical Pressure Despite Strong Fundamentals

Market Snapshot

Takeaway: DuPont de Nemours (DD) is experiencing a rise of 2.72% in price, but our internal diagnostic score (0-10) for technical analysis is just 1.81—suggesting investors should proceed with caution.

News Highlights

• Safex Chemicals Expands in India – The company announced a new facility in Gujarat that could scale up to 80 metric tons per day. While not directly related to DD, this signals growth in the chemical industry, which could indirectly benefit DuPont.
• US-China Trade Tensions Escalate – New US restrictions on shipments of chemicals and chip design software to China may affect DuPont, which has global manufacturing and supply chain exposure. The policy shift adds geopolitical risk to the sector.
• ETF Growth in Asia Pacific – ETFGI reports that assets in the ETF industry in Asia Pacific (excluding Japan) hit a record $1.25 trillion in April. While this is positive for the broader market, it doesn’t directly affect DD’s fundamentals.

Analyst Views & Fundamentals

DuPont de Nemours has attracted attention from three institutions in the past 20 days, with Keybanc, UBS, and RBC Capital issuing ratings. The simple average rating score is 4.33, and the weighted performance-based rating is 3.85, showing mild dispersion in sentiment.

Despite the technical red flags, the fundamental outlook is encouraging. Here are the key factors:

• Operating cycle: 167.93 days – internal diagnostic score: 1.00
• Equity multiplier: 158.51% – internal diagnostic score: 3.00
• Current ratio: 141.15% – internal diagnostic score: 3.00
• Cash-MV: -0.85 – internal diagnostic score: 3.00
• Profit-MV: -2.89 – internal diagnostic score: 1.00

While these metrics suggest solid balance sheet strength, the mixed performance of cash and profit ratios indicates some underlying strain.

The price is up 2.72%, and the weighted expectations of analysts are aligned with the recent positive move. However, the internal diagnostic scores and technical signals suggest the momentum may not be sustainable.

Money-Flow Trends

Big-money players are cautious. The fund flow score is 7.84 (good), but this is driven by mixed inflow ratios across investor types:

• Small investors: 50.06% inflow – trend positive
• Medium investors: 49.96% inflow – trend negative
• Large and extra-large investors: < 50% inflow – trend negative

This suggests retail investors are pushing up the stock, but institutional money is stepping back—possibly a sign of near-term instability.

Key Technical Signals

The technical outlook is bearish, with 5 bearish indicators and 0 bullish signals in the last 5 days. Our internal diagnostic score for the overall technical setup is 1.81—indicating a weak and declining trend.

Here’s a breakdown of the most significant internal diagnostic scores for the latest indicators:

• RSI Overbought: 1.66 – strong bearish signal
• Ex-Dividend Date: 1.27 – bearish impact expected
• Dividend Record Date: 1.27 – bearish pressure
• WR Overbought: 2.68 – neutral to weak
• Bullish Engulfing: 2.19 – mixed signal

Recent chart activity has included:

• 2025-08-29: Ex-Dividend and Dividend Record dates – both bearish signals.
• 2025-08-27: RSI Overbought triggered – bearish momentum likely to continue.

Overall, the key technical insight is that the momentum is weak and bearish indicators dominate. Investors should watch for any signs of a bounce, but be prepared for a possible pullback.

Conclusion

While DuPont de Nemours shows strong fundamental health, the technical and market flow signals point to a weak and potentially declining trend. With internal diagnostic scores at the lower end, we recommend caution or waiting for a clearer breakout signal before entering new long positions.

Watch for a pullback or improved technical confirmation in the next 1–2 weeks before making a move. Until then, the bearish indicators are too strong to ignore.